RxDoctor Payments Data

Larry Sears, MD

Family Medicine · Gainesville, TXNPI 1740395391

Payments from drug & device makers

$15,510in general payments, 2019–2025

Across 269 payments — averaging $57.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$11K
  • Novo Nordisk$906
  • AstraZeneca$877
  • Lilly USA, LLC$247
  • GSK$211
  • Sanofi-aventis U.S. LLC$196
  • plus $2K from 39 others

What the payments were for

  • Food & beverage$4,086100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$15,510 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$6,633
Medicare patients
37
Services billed
107

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide227$295,161
EliquisApixaban185$78,933
TrulicityDulaglutide22$43,812
FarxigaDapagliflozin Propanediol24$31,915
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$27,383
JardianceEmpagliflozin14$25,209
XareltoRivaroxaban26$17,508
Breztri AerosphereBudesonide/Glycopyr/Formoterol24$15,949
MyrbetriqMirabegron19$7,826
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen261$7,295
ErtapenemErtapenem Sodium13$6,464
SymbicortBudesonide/Formoterol Fumarate22$5,310
Duloxetine Hcl181$4,917
Metoprolol Succinate320$4,499
Gabapentin227$4,332

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$906$295,161227 claims
PfizerEliquis$190$78,933185 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$877$53,17470 claims
Lilly USA, LLCTrulicity$247$43,81222 claims
GSKTrelegy Ellipta$211$27,38331 claims
Boehringer IngelheimJardiance$159$25,20914 claims
Johnson & JohnsonXarelto$54$17,50826 claims
Astellas Pharma US IncMyrbetriq$48$7,82619 claims
Sanofi-aventis U.S. LLCLantus$196$2,65421 claims
AbbVieSynthroid$17$2,58458 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Gainesville

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →